Orthofix Medical Inc.
OFIX
$16.30
-$0.46-2.75%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.61% | 6.85% | 6.20% | 7.65% | 63.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.61% | 6.85% | 6.20% | 7.65% | 63.97% |
| Cost of Revenue | 12.37% | -4.19% | -5.33% | -5.41% | 71.68% |
| Gross Profit | 5.72% | 12.77% | 12.71% | 15.33% | 61.11% |
| SG&A Expenses | 3.17% | 6.60% | 0.59% | -7.65% | 56.01% |
| Depreciation & Amortization | 0.49% | 4.14% | -6.80% | 58.83% | 89.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.23% | 2.05% | -2.00% | -6.73% | 59.29% |
| Operating Income | 34.83% | 32.95% | 42.43% | 48.91% | -7.54% |
| Income Before Tax | -34.75% | 6.16% | 14.66% | 41.70% | -215.57% |
| Income Tax Expenses | -551.20% | 59.11% | -28.12% | 39.28% | 66.67% |
| Earnings from Continuing Operations | -31.44% | 5.09% | 15.18% | 40.89% | -213.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.44% | 5.09% | 15.18% | 40.89% | -213.99% |
| EBIT | 34.83% | 32.95% | 42.43% | 48.91% | -7.54% |
| EBITDA | 284.62% | 98.71% | 72.60% | 68.76% | 276.04% |
| EPS Basic | -26.68% | 8.15% | 17.99% | 44.03% | -70.05% |
| Normalized Basic EPS | -74.88% | 18.19% | 27.79% | 42.96% | -12.16% |
| EPS Diluted | -26.68% | 8.15% | 17.95% | 44.19% | -70.05% |
| Normalized Diluted EPS | -74.88% | 18.19% | 27.79% | 42.96% | -12.16% |
| Average Basic Shares Outstanding | 3.75% | 3.33% | 3.42% | 5.62% | 84.65% |
| Average Diluted Shares Outstanding | 3.75% | 3.33% | 3.42% | 5.62% | 84.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
